Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Appointed director Director departure
|
TAURIGA SCIENCES, INC. (TAUG)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/16/2022 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
07/14/2022 |
NT 10-K/A
| Form NT 10-K/A - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: [Amend] |
06/30/2022 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
02/16/2022 |
10-Q
| Quarterly Report for the period ended December 31, 2021 |
02/15/2022 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
11/23/2021 |
8-K
| Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits &... |
11/15/2021 |
10-Q
| Quarterly Report for the period ended September 30, 2021 |
10/12/2021 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
09/30/2021 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
09/22/2021 |
8-K
| Quarterly results |
08/16/2021 |
10-Q
| Quarterly Report for the period ended June 30, 2021 |
08/16/2021 |
10-K/A
| Annual Report for the period ended March 31, 2021 [amend] |
07/23/2021 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Docs:
|
"4 Nancy Court, Suite 4 Wappingers Falls, NY 12590",
"Amazon Brand Registry Approves the Application for the Company’ s Flagship Brand: Tauri-Gum Press Release | 07/06/2021",
"Tauriga Sciences, Inc. and Think BIG, LLC Confirm the Launch of Two Limited-Edition Frank White/Tauri-Gum Versions Press Release | 07/09/2021",
"4 Nancy Court, Suite 4 Wappingers Falls, NY 12590",
"4 Nancy Court, Suite 4 Wappingers Falls, NY 12590" |
|
06/29/2021 |
10-K
| Annual Report for the period ended March 31, 2021 |
03/08/2021 |
8-K
| Quarterly results |
03/05/2021 |
8-K
| Quarterly results |
02/22/2021 |
10-Q
| Quarterly Report for the period ended December 31, 2020 |
02/16/2021 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
01/27/2021 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits |
01/14/2021 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
01/08/2021 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
01/08/2021 |
8-K
| Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits |
12/28/2020 |
SC 13G
| GS Capital Partners, LLC reports a 9.9% stake in TAURIGA SCIENCES, INC. |
11/19/2020 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
11/16/2020 |
10-Q
| Quarterly Report for the period ended September 30, 2020 |
10/01/2020 |
8-K
| Quarterly results |
08/14/2020 |
10-Q
| Quarterly Report for the period ended June 30, 2020 |
07/21/2020 |
8-K
| Quarterly results |
07/14/2020 |
8-K
| Quarterly results |
06/29/2020 |
10-K
| Annual Report for the period ended March 31, 2020 |
06/17/2020 |
8-K
| Other Events |
06/03/2020 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs:
|
"Securities Purchase Agreement between the Company and GS Capital LLC",
"Convertible Note between the Company and GS Capital LLC",
"Securities Purchase Agreement between the Company and Adar Alef, LLC",
"Convertible Note between the Company and Adar Alef, LLC",
"Convertible Note between the Company and Tangiers Global, LLC",
"Securities Purchase Agreement between the Company and Firstfire Global Opportunities Fund, LLC",
"Convertible Note between the Company and Firstfire Global Opportunities Fund, LLC" |
|
04/15/2020 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
03/17/2020 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
|
|
|